LncRNA ASB16-AS1 drives proliferation, migration, and invasion of colorectal cancer cells through regulating miR-185-5p/TEAD1 axis

Mingxu Yu(Wenzhou Medical University), Qing Yang(Guangzhou University of Chinese Medicine), Xiaoju Zhuge(Wenzhou Medical University), Xingcheng Lin(Ningxia University), Shengye Zhuo(Wenzhou Medical University), Tingting Ji(Wenzhou Medical University), Changsheng Shi(Wenzhou Medical University), Dingyin Xu(Wenzhou Medical University), Zhengchao Shi(Wenzhou Medical University)
Cell Cycle
December 6, 2021
10.1080/15384101.2021.1973700
Cited by 16

Related Papers

Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
|JAMA|2021|821
Sumoylation Promotes the Stability of the DNA Sensor cGAS and the Adaptor STING to Regulate the Kinetics of Response to DNA Virus
|Immunity|2016|378
Safety, Activity, and Biomarkers of SHR-1210, an Anti-PD-1 Antibody, for Patients with Advanced Esophageal Carcinoma
|Clinical Cancer Research|2018|218
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 study
|British Journal of Cancer|2018|156
Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
|Science Translational Medicine|2019|138